{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T09:04:43Z","timestamp":1648976683059},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1007\/s00393-006-0133-5","type":"journal-article","created":{"date-parts":[[2007,1,11]],"date-time":"2007-01-11T08:26:55Z","timestamp":1168504015000},"page":"76-77","source":"Crossref","is-referenced-by-count":1,"title":["Neufassung der Empfehlungen der Kommission Pharmakotherapie der DGRh"],"prefix":"10.1007","volume":"66","author":[{"given":"A.","family":"Gause","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,2,1]]},"reference":[{"key":"133_CR1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-2005-857939","volume":"30","author":"Messmer","year":"2005","unstructured":"Messmer EM (2005) Differenzierte Therapie der Keratokonjunktivitis sicca beim Sj\u00f6gren-Syndrom. Akt Rheumatol 30: 59\u201365","journal-title":"Akt Rheumatol"},{"key":"133_CR2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/art.1780270415","volume":"27","author":"Fox","year":"1984","unstructured":"Fox RI, Chan R, Michelson JB et al. (1984). Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 27: 459\u2013461","journal-title":"Arthritis Rheum"},{"key":"133_CR3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/bjo.2003.026211","volume":"88","author":"Noble","year":"2004","unstructured":"Noble BA, Loh RS, MacLennan S et al. (2004) Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease. Br J Ophthalmol 88: 647\u2013652","journal-title":"Br J Ophthalmol"},{"key":"133_CR4","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archinte.159.2.174","volume":"159","author":"Vivino","year":"1999","unstructured":"Vivino FB, Al-Hashimi I, Khan Z et al. (1999) Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92\u201301 Study Group. Arch Intern Med 159: 174\u2013181","journal-title":"Arch Intern Med"},{"key":"133_CR5","doi-asserted-by":"crossref","unstructured":"Tsifetaki N, Kitsos G, Paschides CA et al. (2003) Oral pilocarpine for the treatment of ocular symptoms in patients with Sjogren\u2019s syndrome: a randomised 12 week controlled study. Ann Rheum Dis 62 1204\u20131207","DOI":"10.1136\/ard.2002.003889"},{"key":"133_CR6","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1136\/bmj.1.6127.1579","volume":"1","author":"Frost-Larsen","year":"1978","unstructured":"Frost-Larsen K, Isager H, Manthorpe R (1978) Sjorgren\u2019s syndrome treated with bromhexine: a randomised clinical study. Br Med J 1: 1579\u20131581","journal-title":"Br Med J"},{"key":"133_CR7","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/03009748109095294","volume":"10","author":"Manthorpe","year":"1981","unstructured":"Manthorpe R, Frost-Larsen K, Hoj L et al. (1981) Bromhexine treatment of Sjogren\u2019s syndrome: effect on lacrimal and salivary secretion, and on proteins in tear fluid and saliva. Scand J Rheumatol 10: 177\u2013180","journal-title":"Scand J Rheumatol"},{"key":"133_CR8","first-page":"705","volume":"29","author":"Rhodus","year":"1998","unstructured":"Rhodus NL, Liljemark W, Bloomquist C, Bereuter J (1998) Candida albicans levels in patients with Sjogren\u2019s syndrome before and after long-term use of pilocarpine hydrochloride: a pilot study. Quintessence Int 29: 705\u2013710","journal-title":"Quintessence Int"},{"key":"133_CR9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00300975","volume":"12","author":"Talal","year":"1992","unstructured":"Talal N, Quinn JH, Daniels TE (1992) The clinical effects of electrostimulation on salivary function of Sjogren\u2019s syndrome patients. A placebo controlled study. Rheumatol Int 12: 43\u201345","journal-title":"Rheumatol Int"},{"key":"133_CR10","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/art.510","volume":"46","author":"Petrone","year":"2002","unstructured":"Petrone D, Condemi JJ, Fife R et al. (2002) A double-blind, randomized, placebo-controlled study of cevimeline in Sjogren\u2019s syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum 46: 748\u2013754","journal-title":"Arthritis Rheum"},{"key":"133_CR11","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archinte.162.11.1293","volume":"162","author":"Fife","year":"2002","unstructured":"Fife RS, Chase WF, Dore RK et al. (2002) Cevimeline for the treatment of xerostomia in patients with Sjogren syndrome: a randomized trial. Arch Intern Med 162: 1293\u20131300","journal-title":"Arch Intern Med"},{"key":"133_CR12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","volume":"107","author":"Sall","year":"2000","unstructured":"Sall K, Stevenson OD, Mundorf TK, Reis BL (2000) Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 107: 631\u2013639","journal-title":"Ophthalmology"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-006-0133-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-006-0133-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-006-0133-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T12:29:38Z","timestamp":1559046578000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-006-0133-5"}},"subtitle":["Empfehlungen zur supportiven Therapie des Sj\u00f6gren-Syndroms"],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["133"],"URL":"https:\/\/doi.org\/10.1007\/s00393-006-0133-5","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}